Real-world immunotherapy (IO) rechallenge outcomes with nivolumab (NIV) in advanced non-small cell lung cancer (aNSCLC) in France: LIST study interim results

被引：0
|
作者：
Godbert, B. [1 ]
Gobbini, E. [2 ]
Zysman, M. [3 ]
Decroisette, C. [4 ]
Lena, H. [5 ]
Moro-Sibilot, D. [6 ]
Guisier, F. [7 ]
Egenod, T. [8 ]
Couraud, S. [9 ]
Brellier, F. [10 ]
Fleuriet, A. [11 ]
Khalife, Y. [12 ]
Girard, N. [13 ]
机构：
[1] Hop Robert Schuman UNEOS, Pneumol, Metz, France
[2] Inst Curie, Thorac Oncol Dept, Paris, France
[3] Univ Hosp Bordeaux, Pneumol, Bordeaux, France
[4] Ctr Leon Berard, Thorac Oncol, Lyon, France
[5] Univ Hosp Rennes, Pneumol, Rennes, France
[6] CHU Grenoble Alpes Site Nord La Tronche, Thorac Oncol Dept, Hop Michallon, La Tronche, France
[7] CHU Rouen Normandie, Pneumol, Rouen, France
[8] CHU Limoges Hop Dupuytren, Thorac Oncol, Limoges, France
[9] Hospices Civils Lyon, Serv Pneumol, Lyon, France
[10] Bristol Myers Squibb Pharmaceut Ltd Uxbridge, Ctr Observat Res & Data Sci, Uxbridge, England
[11] Bristol Myers Squibb, Clin, Bristol, France
[12] Bristol Myers Squibb, Med Affairs, Rueil Malmaison, France
[13] Inst Curie, Thorax Inst, Paris, France
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1373
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1317P
引用
收藏
页码：S838 / S839
页数：2
相关论文
共 50 条
  • [1] Real-World Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer (aNSCLC) in the US
    Nadler, E.
    Chang, J.
    Zhang, X.
    Aguilar, K.
    Zhou, J.
    Arondekar, B.
    Pawar, V.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S38 - S39
  • [2] Real-world treatment sequencing in advanced non-small cell lung cancer (aNSCLC).
    Radtchenko, Janna
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] A real-world prospective study of nivolumab (NIVO) in patients (pts) with pretreated advanced non-small cell lung cancer (aNSCLC) in Greece and Cyprus - Interim analysis results of LUCENCE study
    Charpidou, Andriani
    Mani, Maria
    Lampaki, Sofia
    Stournara, Lambrini
    Kotsakis, Athanasios
    Samantas, Epameinodas
    Grammatikou, Violeta
    Kentepozidis, Nikolaos
    Koumarianou, Anna
    Syrigos, Konstantinos
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [4] Nivolumab (nivo) resumption in patients with advanced or metastatic non-small cell lung cancer (aNSCLC): Survival outcomes based on France and Germany real-world data (RWD)
    Perol, M.
    Sebastian, M.
    Barlesi, F.
    Schumann, C.
    Reynaud, D.
    Waldenberger, D.
    Lee, A.
    Varol, N.
    Penrod, J. R.
    Brellier, F.
    ANNALS OF ONCOLOGY, 2023, 34
  • [5] Nivolumab treatment in advanced non-small cell lung cancer (aNSCLC): Real-world 3-year outcomes within overall and special populations (the UNIVOC study)
    Assie, J-B.
    Corre, R.
    Levra, M. Giaj
    Calvet, C. Y.
    Grumberg, V.
    Gaudin, A-F.
    Jouaneton, B.
    Cotte, F-E.
    Chouaid, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S825 - S825
  • [6] Real-world prognostic value of RET fusions in advanced non-small cell lung cancer (aNSCLC)
    Gadgeel, S. M.
    Zhang, Q.
    Lin, H.
    Fajardo, O.
    Trinh, H.
    Arndorfer, S.
    Kong, S.
    Rahman, A.
    Li, S.
    Archer, V. R.
    Gainor, J. F.
    ANNALS OF ONCOLOGY, 2023, 34
  • [7] Nivolumab Outcomes in Octogenarian Patients with Advanced Non-Small Cell Lung Cancer in French Real-World Setting
    Assie, J.
    Cotte, F.
    Levra, M. Giaj
    Calvet, C.
    Jolivel, R.
    Jouaneton, B.
    Gaudin, A.
    Grumberg, V.
    Chouaid, C.
    Corre, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S708 - S708
  • [8] Immunotherapy rechallenge after nivolumab treatment in advanced non small cell lung cancer in the real-world setting: A national data base analysis
    Levra, Matteo Giaj
    Cotte, Francois-Emery
    Corre, Romain
    Calvet, Christophe
    Gaudin, Anne-Francoise
    Penrod, John R.
    Grumberg, Valentine
    Jouaneton, Baptiste
    Jolivel, Ronan
    Assie, Jean-Baptiste
    Chouaid, Christos
    LUNG CANCER, 2020, 140 : 99 - 106
  • [9] Trends in immunotherapy use in patients with advanced non-small cell lung cancer (aNSCLC) patients: Analysis of real-world data.
    Kushi, Lawrence H.
    Lasiter, Laura
    Belli, Andrew J.
    Boyd, Marley
    Bruinooge, Suanna S.
    Christian, Jennifer
    Garrett-Mayer, Elizabeth
    Hansen, Eric
    Honnold, Rebecca
    Benito, Ruth Pe
    Natanzon, Yanina
    Sakoda, Lori
    Rivera, Donna R. R.
    Rhodes, Whitney
    Robert, Nicholas J.
    Sharon, Elad
    Sweetnam, Connor
    Wagner, Joseph
    Walker, Mark S.
    Allen, Jeff
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Nivolumab outcomes in interstitial lung disease patients with advanced non-small cell lung cancer in French real-world setting
    Assie, J-B.
    Chouaid, C.
    Nunes, H.
    Reynaud, D.
    Gaudin, A-F.
    Grumberg, V.
    Jolivel, R.
    Jouaneton, B.
    Cotte, F-E.
    Duchemann, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S1418 - S1418
12345